-
Report accuses Covid vaccine makers of putting profits before lives
cphi-online
September 28, 2021
Only 0.3% of the 5.76 billion doses administered worldwide have been distributed to low-income countries
-
Banty's Dr. Richard Tytus Discusses How to Prepare Medical Clinics for Virtual Visits with Patients
prnewswire
September 28, 2021
Because of the ongoing COVID-19 global pandemic, more and more medical clinics are beginning to explore the usage of a telemedicine solution.
-
Brii Bio Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy
prnasia
September 28, 2021
Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens...
-
Senhwa Announces Acceptance of Early Positive COVID-19 Phase II Study Abstract for Presentation at the ISIRV-WHO Conference
prnewswire
September 28, 2021
Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today announced the acceptance...
-
NRx Pharmaceuticals Announces Improved Survival at One Year in Highly Comorbid COVID-19 Patients Treated with ZYESAMI (aviptadil)
prnewswire
September 28, 2021
NRx Pharmaceuticals (Nasdaq: NRXP), a clinical stage, biopharmaceutical company, today announced top line data demonstrating improved outcomes at one year in highly comorbid patients with COVID-19 who were treated with ZYESAMI™.
-
Gates Foundation's Annual Goalkeepers Report Finds Stark Disparities in COVID-19 Impacts
prnasia
September 23, 2021
New data reveals world stepped up to prevent worst-case scenarios from happening; spotlights need for long-term investments to ensure an equitable recovery and continued progress toward the Global Goals.
-
RedHill Biopharma Reports Top-Line Data from Opaganib Phase 2/3 Study in Severe COVID-19 Patients
prnewswire
September 23, 2021
While preliminary top-line data of the study efficacy endpoints showed consistent trends in favor of the opaganib arm, the study endpoints did not achieve statistical significance
-
Liver Disease Patients Struggle with Healthy Habits During the Covid-19 Pandemic, Data Show
prnewswire
September 23, 2021
Nutrition and lifestyle are considered the most important factors for liver health. However, when the Covid-19 pandemic disrupted our daily lives, liver disease patients experienced a downturn in their healthy habits.
-
Survey Finds Satellite Internet Essential for Tele-health Services, Work-from-Home Applications and General Communications During Ongoing COVID-19 Pandemic
prnewswire
September 23, 2021
Viasat Inc. (NASDAQ: VSAT), a global communications company, today revealed results from its 2021 consumer connectivity survey showing the role satellite-based connectivity...
-
Therapeutic Solutions International Identifies and Files Patent on Combination Effects Between its Nutraceutical QuadraMune™ and Ivermectin in Animal Models of COVID-19 Pathology
prnewswire
September 23, 2021
Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today new data demonstrating positive effects when its commercially available nutraceutical, QuadraMune™...